SCHEMBL2990779

SCHEMBL2990779

CC(C)C[C@H](N)C(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 2/20 0.66
LARS1 Q9P2J5 1/20 0.63
DNPH1 O43598 7/20 0.63
P2RY1 P47900 4/20 0.63
TAS1R3 Q7RTX0 2/20 0.63
TAS1R1 Q7RTX1 2/20 0.63
P2RY2 P41231 2/20 0.63
PRKAB2 O43741 1/20 0.63
TRPM2 O94759 1/20 0.63
LDHA P00338 1/20 0.63
ADRB2 P07550 1/20 0.63
FBP1 P09467 1/20 0.63
SRC P12931 1/20 0.63
ADORA1 P30542 1/20 0.63
PRKAG1 P54619 1/20 0.63
PRKAA2 P54646 1/20 0.63
PDE4D Q08499 1/20 0.63
KCNH2 Q12809 1/20 0.63
PRKAA1 Q13131 1/20 0.63
PDE3A Q14432 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8916648 0.92 P2RY12 (0.70) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL1933421 0.91 P2RY12 (0.67) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL4997219 0.91 P2RY12 (0.69) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL5545796 0.91 P2RY12 (0.69) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL2988353 0.90 P2RY12 (0.68) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL2990348 0.90 P2RY12 (0.68) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL3193571 0.90 P2RY12 (0.68) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL18274661 0.89 P2RY12 (0.71) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL8570660 0.88 MARS1 (0.65) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL3898255 0.88 P2RY12 (0.65) P2RY12DNPH1P2RY1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2758775-B1 NOVEL USE OF LEUCYL TRNA SYNTHETASE MEDICINAL BIOCONVERGENCE RES CT (KR) 2017-08-16 EP disclosed
US-9435807-B2 Use of leucyl tRNA synthetase MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) 2016-09-06 US disclosed
US-20140249045-A1 NOVEL USE OF LEUCYL TRNA SYNTHETASE MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) 2014-09-04 US disclosed
EP-2758775-A2 NOVEL USE OF LEUCYL TRNA SYNTHETASE Medicinal Bioconvergence Research Center (KR) 2014-07-30 EP disclosed
CN-103959058-A Novel use of leucyl tRNA synthetase MEDICINAL BIOCONVERGENCE RES CT 2014-07-30 CN disclosed
WO-2013043012-A2 NOVEL USE OF LEUCYL TRNA SYNTHETASE MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) 2013-03-28 WO disclosed
US-7785827-B2 Method and composition for leucyl-tRNA synthetases and derivatives thereof that activate and aminoacylate non-leucine amino acid to tRNA adaptor molecules UNIVERSITY OF HOUSTON SYSTEM (US) 2010-08-31 US disclosed
US-20040203094-A1 Eucyl-tRNA synthetases and derivatives thereof that activate and aminoacylate non-leucine amino acids to tRNA adaptor molecules BOARD OF REGENTS, UNIVERSITY OF HOUSTON 2004-10-14 US disclosed